Cargando…

Low Meningococcal Vaccination Rates Among Patients With Newly Diagnosed Complement Component Deficiencies in the United States

Meningococcal vaccination is recommended for patients with complement component deficiencies (CDs) in the United States. In this retrospective database study, only 4.6% and 2.2% of patients received MenACWY and MenB vaccination, respectively, within 3 years of CD diagnosis. Thus, meningococcal vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marshall, Gary S, Ghaswalla, Parinaz K, Bengtson, Lindsay G S, Buikema, Ami R, Bancroft, Tim, Koep, Eleena, Novy, Patricia, Hogea, Cosmina S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402647/ https://www.ncbi.nlm.nih.gov/pubmed/34718466 http://dx.doi.org/10.1093/cid/ciab917

Ejemplares similares

26. Factors Associated with Meningococcal Vaccination among Patients with Newly Diagnosed High-Risk Conditions
por: Ghaswalla, Parinaz, et al.
Publicado: (2020)

2726. Meningococcal Vaccination Among Patients Newly Diagnosed at High-Risk for Meningococcal Disease in the United States
por: Bengtson, Lindsay, et al.
Publicado: (2019)

Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US
por: Ghaswalla, Parinaz K., et al.
Publicado: (2022)

Determinants of Meningococcal ACWY vaccination in adolescents in the US: completion and compliance with the CDC recommendations
por: Cheng, Wendy Y., et al.
Publicado: (2019)

Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis
por: Packnett, Elizabeth R., et al.
Publicado: (2023)

Development and validation of a drug adherence index for COPD
por: Bengtson, Lindsay G S, et al.
Publicado: (2021)

2459. Meningococcal ACWY (MenACWY) Vaccination of Adolescents in the United States: How Compliant Are We With the Advisory Committee on Immunization Practices (ACIP) Recommendations?
por: Cheng, Wendy, et al.
Publicado: (2018)

A Real-world Claims Data Analysis of Meningococcal Serogroup B Vaccine Series Completion and Potential Missed Opportunities in the United States
por: Packnett, Elizabeth R., et al.
Publicado: (2022)

The effect of delaying initiation with umeclidinium/vilanterol in patients with COPD: an observational administrative claims database analysis using marginal structural models
por: Buikema, Ami R., et al.
Publicado: (2018)

Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study
por: Moretz, Chad, et al.
Publicado: (2019)

Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol
por: Moretz, Chad, et al.
Publicado: (2019)

Meningococcal disease and the complement system
por: Lewis, Lisa A, et al.
Publicado: (2014)

Meningococcal meningitis and complement deficiences
por: Aoki, Aline Lury, et al.
Publicado: (2015)

179. Individual and State-level Factors Associated with Receipt of Multiple Recommended Adolescent Vaccines in the United States
por: La, Elizabeth M, et al.
Publicado: (2020)

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers
por: Singer, David, et al.
Publicado: (2020)

A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp
por: Konar, Monica, et al.
Publicado: (2015)

Terminal Complement Pathway Deficiency in an Adult Patient with Meningococcal Sepsis
por: Staels, F., et al.
Publicado: (2022)

Invasive meningococcal disease in three siblings with hereditary deficiency of the 8(th) component of complement: evidence for the importance of an early diagnosis
por: Dellepiane, Rosa Maria, et al.
Publicado: (2016)

Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
por: Studer, Sean, et al.
Publicado: (2018)

Treatment Compliance Communications Between Patients with Severe Mental Illness and Treating Healthcare Providers: A Retrospective Study of Documentation Using Healthcare Reimbursement Claims and Medical Chart Abstraction
por: Martin, Carolyn, et al.
Publicado: (2021)

Complement 4 Aids in the Prediction of Newly Diagnosed Multiple Myeloma Outcome in Patients
por: Zhang, Lihua, et al.
Publicado: (2022)

Complement Fixation in Meningococcal Infections as an Aid to Diagnosis: With Note on Clinical Standpoint
por: Cookson, H. A., et al.
Publicado: (1932)

The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
por: Lewis, Lisa A., et al.
Publicado: (2010)

Rotavirus vaccination in the US: a systematic review of vaccination coverage and completion
por: Ghaswalla, Parinaz K., et al.
Publicado: (2020)

Exploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement
por: Hogea, Cosmina, et al.
Publicado: (2015)

A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?
por: Hogea, Cosmina, et al.
Publicado: (2014)

Multi‐component meningococcal serogroup B (MenB)‐4C vaccine induces effective opsonophagocytic killing in children with a complement deficiency
por: van den Broek, B., et al.
Publicado: (2019)

A Case of Meningococcal Sepsis and Meningitis with Complement 7 Deficiency in a Military Trainee
por: Sim, Sung Hoon, et al.
Publicado: (2013)

Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017)
por: Ladhani, Shamez N., et al.
Publicado: (2019)

Recurrent meningococcal meningitis with complement 6 (C6) deficiency: A case report
por: Bae, Ji Yun, et al.
Publicado: (2020)

Alternative Complement Pathway Inhibition Does Not Abrogate Meningococcal Killing by Serum of Vaccinated Individuals
por: Ispasanie, Emma, et al.
Publicado: (2021)

Control of meningococcal meningitis with meningococcal vaccines.
por: Artenstein, M. S.
Publicado: (1975)

ROLE OF MENINGOCOCCAL ENDOTOXIN IN MENINGOCOCCAL PURPURA
por: Davis, Charles E., et al.
Publicado: (1974)

Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
por: Van Effelterre, Thierry P, et al.
Publicado: (2015)

US College Students Are at Increased Risk for Serogroup B Meningococcal Disease
por: Marshall, Gary S, et al.
Publicado: (2019)

Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review
por: Marshall, Gary S., et al.
Publicado: (2022)

The Burden of Infant Meningococcal Disease in the United States
por: Judelsohn, R., et al.
Publicado: (2012)

2278. Maternal Immunization Rates With Tetanus–Diphtheria–Acellular Pertussis and Influenza Vaccines in the United States: A Retrospective Claims Database Analysis
por: Ghaswalla, Parinaz, et al.
Publicado: (2018)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection
por: Hogea, Cosmina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fa34ufsm3ua6smitch94u3ccin